GlassScriptPhysician profile
Joseph C Yu
NPI 1447510334
$7,023.11
in general payments reported to CMS, 2019-2025
31 companies · $1,078 in 2025
The $1,078 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2020: $153 · 2021: $518 · 2022: $1,718 · 2023: $1,363 · 2024: $1,797 · 2025: $1,078.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,238.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $857.48 | 2021-2025 | |
| Abiomed | $574.68 | 2023-2025 | Impella |
| Abbott Laboratories | $500.88 | 2019-2023 | Gallant |
| Merck Sharp & Dohme LLC | $495.94 | 2022-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $468.79 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $409.67 | 2021-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $390.14 | 2021-2025 | Jardiance |
| Cardiovascular Systems INC. | $371.56 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $328.37 | 2022-2024 | |
| Pfizer INC. | $271.93 | 2024-2025 | |
| Amgen INC. | $259.12 | 2022-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $203.35 | 2023-2025 | Farxiga, Andexxa |
| Boston Scientific Corporation | $183.63 | 2023-2025 | General - Tachy, Wolverine Coronary Cutting Balloon, Ranger |
| Kiniksa Pharmaceuticals, LTD. | $182.51 | 2021-2023 | Arcalyst |
| Recor Medical INC | $172.67 | 2025 | Paradise Ultrasound Renal Denervation System |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $171.03 | 2024 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $167.28 | 2022-2024 | Onpattro |
| Amarin Pharma, INC. | $147.76 | 2022-2023 | |
| Medtronic, INC. | $133.38 | 2021-2024 | Reveal Linq |
| Novo Nordisk INC | $119.71 | 2022-2024 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $84.17 | 2022-2024 | |
| Lantheus Medical Imaging, INC. | $82.52 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $74.62 | 2023-2024 | Eliquis, Camzyos |
| Lexicon Pharmaceuticals, INC. | $70.19 | 2023-2024 | Inpefa |
| Baxter Healthcare | $68.50 | 2022-2023 | Hillrom - Carnation Ambulatory Monitor |
| Resmed Corp | $60.69 | 2022 | |
| Kestra Medical Technology Services, INC. | $59.46 | 2023 | Assure Wcd |
| Cvrx, INC. | $52.69 | 2024 | Barostim Neo System |
| Irhythm Technologies, INC. | $25.59 | 2024 | Zio Xt Patch, Zio Monitor |
| Actelion Pharmaceuticals US, INC. | $21.77 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.